Singapore markets open in 2 hours 47 minutes

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.52+0.09 (+0.18%)
At close: 04:00PM EDT
50.35 -0.17 (-0.34%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close50.43
Bid50.26 x 2200
Ask50.40 x 3100
Day's range50.36 - 50.79
52-week range13.11 - 50.90
Avg. volume1,870,446
Market cap3.605B
Beta (5Y monthly)1.66
PE ratio (TTM)N/A
EPS (TTM)-2.01
Earnings date09 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est76.57
  • Zacks

    Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx

    Amgen (AMGN) beats Q2 estimates for earnings and sales. It offers to buy ChemoCentryx (CCXI) for $3.7 billion.

  • Zacks

    ChemoCentryx (CCXI) Moves 109.2% Higher: Will This Strength Last?

    ChemoCentryx (CCXI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

  • Motley Fool

    Why ChemoCentryx Stock Is On Fire Today

    Shares of ChemoCentryx (NASDAQ: CCXI) skyrocketed by as much as 110% in premarket trading Thursday morning. The company's stock bolted higher following the news that biotech heavyweight Amgen (NASDAQ: AMGN) offered $3.7 billion in cash to acquire the rare-disease specialist. The deal represents a whopping 116% premium relative to where ChemoCentryx's shares closed on Wednesday.